Table 3 Raw counts of preventive care reminders delivered by the cloud-based CDSC rules and the locally-crafted CARE rules
From: Measuring agreement between decision support reminders: the cloud vs. the local expert
Reminder | Both rules | CDSC rule, not CARE | CARE rule, not CDSC | Neither rule | P0 |
|---|---|---|---|---|---|
| Â | N | N | N | N | Â |
| Â | (%) | (%) | (%) | (%) | Â |
1. Overdue for A1c | 85 (21%) | 20 (5%) | 7 (72%) | 293 | 0.93 |
2. Almost due for A1c | 11 (3%) | 1 (<1%) | 2 (97%) | 391 | 0.99 |
3. Recent A1c was over 8 | 4 (1%) | 4 (1%) | 15 (4%) | 382 (94%) | 0.95 |
4. Due for microalbumin screening | 110 (27%) | 15 (4%) | 32 (8%) | 248 (61%) | 0.88 |
5. Renal disease, consider ACE inhibitor | 12 (3%) | 34 (8%) | 44 (11%) | 315 (78%) | 0.81 |
6. Renal disease, contraindications for ACE inhibitor, consider ARB | 1 (<1%) | 0 (0%) | 3 (1%) | 401 (99%) | 0.99 |
7. Due for eye exam | 204 (50%) | 12 (3%) | 8 (2%) | 181 (45%) | 0.95 |
8. Due for foot exam | 140 (35%) | 27 (7%) | 7 (2%) | 231 (57%) | 0.92 |
9. Due for blood pressure | 84 (21%) | 127 (31%) | 9 (2%) | 185 (46%) | 0.66 |
10. CAD, consider anti-platelet | 35 (9%) | 8 (2%) | 72 (18%) | 290 (72%) | 0.80 |
11. CAD, consider anti-platelet, but contraindications exist | 2 (<1%) | 29 (7%) | 2 (<1%) | 372 (92%) | 0.92 |